What is the size of the CDMO market in 2023?

The Eyewear market size is USD 161 billion in 2023.

What is the projected CAGR at which the Eyewear market is expected to grow at?

The Eyewear market is expected to grow at a CAGR of 6.9% (2024-2033).

List the key industry players of the Eyewear market?

Lonza, Wuxi, Catalent, FAREVA SA, Recipharm AB, Samsung Biologics, Delpharm, Siegfried, Boehringer Ingelheim, Aenova Group, Labcorp Drug Development, Thermo Fisher Scientific Inc., Parexel International Corporation

Which region is more appealing for vendors employed in the Eyewear market?

North America is expected to account for the highest revenue share of 35.1% and boasting an impressive market value of USD 56.5 billion. Therefore, the Eyewear industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for Eyewear?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the Eyewear Market.

CDMO Market By Product Type (Hair Products, Lip Products, Skin Products, Eye Products, Body Hygiene), By CMO Type (Api, Finished Product, And Packaging), By CRO Type (Discovery, Preclinical, Clinical Trial) By Region And Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2024-2033

Published date: Aug 2024
Report ID: 96778
Number of Pages: 278
Format:

Overview
Table of Contents
Major Market Players
Request a Free Sample

- Lonza
- Wuxi
- Catalent
- FAREVA SA
- Recipharm AB
- Samsung Biologics
- Delpharm
- Siegfried
- Boehringer Ingelheim
- Aenova Group
- Labcorp Drug Development
- Thermo Fisher Scientific Inc.
- Parexel International Corporation
- Other Key Players.